Document is current

Article History

Received: 4 July 2020

Accepted: 11 November 2020

First Online: 27 November 2020

Ethics approval and consent to participate

: The study was approved by the Institutional Review Board that is Institute Human Ethics Committee of National JALMA Institute for Leprosy and Other Mycobacterial Diseases, (Indian Council of Medical Research), Dr. M. Miyazaki Marg, Tajganj, Agra-282004. The registration number of Institute Human Ethics Committee was ECR/257/Inst/ UP/ 2013. The ethics committee meeting was held on 27.5.2016 at National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra for the project entitled “Characterization of drug resistant HIV-1 mutants of Agra region, India by genomic and proteomic approaches”. Renewal of registration of Institute Human Ethics Committee of National JALMA Institute for leprosy and Other Mycobacterial Diseases was done by Central Drugs Standard Control Organization (CDSCO) with registration no. ECR/257/Inst/UP/2013/RR-20 dated 19th June 2020 and provisional registration with department of Health Research, Ministry of Health and Family Welfare, Govt. of India, File number- EC/NEW/INST/2020/792 dated 27th July 2020.The study protocol and informed consent was approved by Institute Human Ethics Committee of National JALMA Institute for Leprosy and Other Mycobacterial Diseases, (Indian Council of Medical Research), Dr. M. Miyazaki Marg, Tajganj, Agra-282004. The Institute Human Ethics Committee is constituted as per the guidelines directed by the Indian Council of Medical Research, Govt. of India. Details of the research plan of the study were informed to the patients in local (Hindi) language in written form. Then the written informed consent was obtained from the study participants.

: Not Applicable.

: “No competing financial interests exist.”